| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/18/2008 | US20080312199 Treatments of therapy resistant diseases and drug combinations for treating the same |
| 12/18/2008 | US20080312198 Pharmaceutical products containing hormones and a 25-hydroxy vitamin d compound |
| 12/18/2008 | US20080312197 Pharmaceutical products containing hormones and a 25-hydroxy vitamin d compound |
| 12/18/2008 | US20080312196 Topical wart removal composition |
| 12/18/2008 | US20080312195 Preservatives |
| 12/18/2008 | US20080312194 Methods and compositions for normalizing meibomian gland secretions |
| 12/18/2008 | US20080312193 Substituted Tetracycline Compounds for Treatment of Inflammatory Skin Disorders |
| 12/18/2008 | US20080312192 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases |
| 12/18/2008 | US20080312191 Novel Urokinase Inhibitors |
| 12/18/2008 | US20080312190 Organophosphoric Derivatives Useful as Anti-Parasitic Agents |
| 12/18/2008 | US20080312189 Cadasil Treatment with Cholinesterase Inhibitors |
| 12/18/2008 | US20080312188 Glycogen synthase kinase-3 inhibitors |
| 12/18/2008 | US20080312187 Phosphoinositide modulation for the treatment of alzheimer's disease |
| 12/18/2008 | US20080312186 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| 12/18/2008 | US20080312185 SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES |
| 12/18/2008 | US20080312183 3-benzoyl-1-[(Z)-4-(trityloxy)-2-butenyl]-1,2,3,4-tetrahydro-2,4-pyrimidinedione; antiprotozoa agents; Deoxyuridine triphosphate nucleotidohydrolase inhibitors; malaria |
| 12/18/2008 | US20080312182 Ophthalmic composition with hyaluronic acid and polymeric biguanide |
| 12/18/2008 | US20080312181 Composition and Methods for Skin Care |
| 12/18/2008 | US20080312180 Methods to Protect Skeletal Muscle Against Injury |
| 12/18/2008 | US20080312179 High level expression of recombinant human erythropoietin having a modified 5'-UTR |
| 12/18/2008 | US20080312178 Human G-Protein Receptor HGBER32 |
| 12/18/2008 | US20080312176 Gene silencing |
| 12/18/2008 | US20080312175 Methods and compositions for regulating hdac4 activity |
| 12/18/2008 | US20080312174 Water soluble crosslinked polymers |
| 12/18/2008 | US20080312173 Treatment of HSV-related pathologies using plasmids that make ssDNA |
| 12/18/2008 | US20080312172 Anti-IL-6 Antibodies, Compositions, Methods and Uses |
| 12/18/2008 | US20080312171 Tetracycline-Dependent Regulation of Rna Interference |
| 12/18/2008 | US20080312170 Fibrinolysin of Agkistrodon Acutus Venom and its Usage |
| 12/18/2008 | US20080312169 Cosmetic use of D-ribose |
| 12/18/2008 | US20080312168 Novel Dispersible Tablet Composition |
| 12/18/2008 | US20080312167 4'' Amino Linked Macrolides Useful for the Treatment of Microbial Infections |
| 12/18/2008 | US20080312166 Reversal core pharmaceutical system and method |
| 12/18/2008 | US20080312165 Process for obtaining pure monosialoganglioside GM1 for medical use |
| 12/18/2008 | US20080312164 Isothiocyanates and glucosinolate compounds and anti-tumor compositions containing same |
| 12/18/2008 | US20080312163 Treatment of pulmonary hypertension with carbonic anhydrase inhibitors |
| 12/18/2008 | US20080312162 Methods and Compositions for Enzyme-Specific Activation of Carbohydrate-Conjugated Prodrugs |
| 12/18/2008 | US20080312160 Method of treating enteritis, intestinal damage, and diarrhea from c. difficile with an a2a adenosine receptor agonist |
| 12/18/2008 | US20080312153 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 12/18/2008 | US20080312150 Treatment and analysis of proliferative disorders |
| 12/18/2008 | US20080312145 Agent for Regulating Bone Formation |
| 12/18/2008 | US20080312143 Modified Cdna for High Expression Levels of Factor VIII and Its Derivatives |
| 12/18/2008 | US20080312138 Erythropoietin complementation or replacement |
| 12/18/2008 | US20080312134 Vesicles for active macromolecule delivery |
| 12/18/2008 | US20080312132 Composition for animal consumption |
| 12/18/2008 | US20080312130 Drug delivery vehicle for cancer therapy, process for producing the same, and pharmaceutical preparation using the same |
| 12/18/2008 | US20080312128 Cellular Biomarker Antioxidant Assay and Uses Thereof |
| 12/18/2008 | US20080312098 Use of a Gip Promoter Polymorphism |
| 12/18/2008 | US20080312087 2-Propenal and Related Enal Compounds for Controlling Plant Pests and Weeds in Soil |
| 12/18/2008 | US20080311644 Amino Methylated 2-Pyridinones |
| 12/18/2008 | US20080311608 Antagonist of the oncogenic activity of the protein MDM2, and use thereof in the treatment of cancers |
| 12/18/2008 | US20080311556 Sense Antiviral Compound and Method for Treating Ssrna Viral Infection |
| 12/18/2008 | US20080311232 Cooling Compounds |
| 12/18/2008 | US20080311231 Broad Spectrum Non-Traditional Preservative System |
| 12/18/2008 | US20080311228 Pharmaceutical composition for protecting neurons comprising extract of lithospermum erythrothizon sieb. et. zucc or acetylshikonin isolated therefrom as an effective ingredient |
| 12/18/2008 | US20080311223 Injectable polymer-lipid blend for localized drug delivery |
| 12/18/2008 | US20080311218 Topical composition for treating pain |
| 12/18/2008 | US20080311217 Topicial composition for treating pain |
| 12/18/2008 | US20080311212 Crystalline isoxazole derivative and pharmaceutical preparation thereof |
| 12/18/2008 | US20080311210 Pharmaceutical composition for use as a laxative |
| 12/18/2008 | US20080311209 Topical compositions comprising nanoparticles of an isoflavone |
| 12/18/2008 | US20080311208 Pharmaceutical Formulations Useful in the Treatment of Insomnia |
| 12/18/2008 | US20080311205 Abuse resistant drug formulation |
| 12/18/2008 | US20080311204 Stable oral formulation containing benzimidazole derivative |
| 12/18/2008 | US20080311203 Oral Formulation of Anhydrous Olanzapine Form I |
| 12/18/2008 | US20080311202 Pharmaceutical Composition Containing Donepezil Hydrochloride, Tablets Produced Therefrom and Methods for Producing the Same |
| 12/18/2008 | US20080311201 Modified release solid or semi-solid dosage forms |
| 12/18/2008 | US20080311200 Controlled Slow Release Formulation of Thiamine and Use Thereof in the Treatment of Pathologies Connected to Defective Process of Learning and Memorization |
| 12/18/2008 | US20080311199 Tamper-resistant oral opioid agonist formulations |
| 12/18/2008 | US20080311198 Tamper-resistant oral opioid agonist formulations |
| 12/18/2008 | US20080311197 Process for the production of an abuse-proofed dosage form |
| 12/18/2008 | US20080311196 All Day Rhinitic Condition Treatment Regimen |
| 12/18/2008 | US20080311194 Dispersible Tablets Comprising Deferasirox |
| 12/18/2008 | US20080311193 Sustained Release Formulation of Alprazolam |
| 12/18/2008 | US20080311189 Compositions Comprising Organometallic Molybdenum Compounds For Treating Cancer |
| 12/18/2008 | US20080311188 Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol |
| 12/18/2008 | US20080311187 Crush resistan delayed-release dosage form |
| 12/18/2008 | US20080311186 Composition Having Effect on Treatment and Prevention of Dry Eye Syndrome |
| 12/18/2008 | US20080311185 Deregulated Genes and/or Processes in Inflammatory Arthritis |
| 12/18/2008 | US20080311184 Method for developing, testing, and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates |
| 12/18/2008 | US20080311183 Novel Inhibitors of Pyruvate Kinase as Therapeutic Agents for Cancer |
| 12/18/2008 | US20080311181 Serum-Stable Amphoteric Liposomes |
| 12/18/2008 | US20080311180 Method of Preventive On-Demand Hormonal Contraception |
| 12/18/2008 | US20080311179 for treating disease or condition chosen from Parkinson's disease, Huntington's chorea, schizophrenia, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, age related cognitive decline, sleep, eating disorders |
| 12/18/2008 | US20080311176 Drug Condensation Aerosols And Kits |
| 12/18/2008 | US20080311171 Implantable polymeric device for sustained release of dopamine agonist |
| 12/18/2008 | US20080311169 Composition Comprising Ginsenosides for Treating or Preventing Angiostenosis and Restenosis |
| 12/18/2008 | US20080311167 Topical Composition for Treating Pain |
| 12/18/2008 | US20080311162 Film to encapsulate pharmaceutical, agrochemical, detergent active ingredients; fill material less compacted than in a tablet but more than in a capsule; controlled release; fewer, lower quantities of excipients |
| 12/18/2008 | US20080311161 Compositions and Methods for Enhanced Gastrointestinal Stability of Oligopeptides and Polypeptides |
| 12/18/2008 | US20080311160 Clear Pharmaceutical Aqueous Emulsion Composition Which Comprises Propofol and Process for Preparing this Composition |
| 12/18/2008 | US20080311156 Vaccines |
| 12/18/2008 | US20080311126 Antisense Oligonucleotides Directed to Ribonucleotide Reducatase R2 and Uses Thereof in Combination Therapies for the Treatment of Cancer |
| 12/18/2008 | US20080311124 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 12/18/2008 | US20080311123 Compositions and methods for the therapy and diagnosis of breast cancer |
| 12/18/2008 | US20080311122 Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof |
| 12/18/2008 | US20080311112 Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4-associated disorders |
| 12/18/2008 | US20080311109 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 12/18/2008 | US20080311102 Nucleic acid molecule that encodes the MGAT-X1 protein; pharmaceutical composition containing the nucleic acid or its expression vector |
| 12/18/2008 | US20080311100 Treatment of Keratinous Dryness With Glycerides |
| 12/18/2008 | US20080311099 Pyridoxal-5-Phosphate and Related Compounds in Combination With Therapeutic Cardiovascular Compounds for Treating Angina |